Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study

Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study

Abstract Background and aims Innovative treatment modalities have not yet shown a clinical benefit in patients with septic shock. To reduce severe cytokinaemia, CytoSorb as an add-on to continuous renal replacement therapy (CRRT) showed promising results in case reports. However, there are no clinic...

Full description

Bibliographic Details
Main Authors: Willem Pieter Brouwer, Servet Duran, Martijn Kuijper, Can Ince
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Critical Care
Subjects:
Sepsis
Septic shock
Treatment
Hemofiltration
Cytosorb
Cytosorbent
Online Access:http://link.springer.com/article/10.1186/s13054-019-2588-1

Internet

http://link.springer.com/article/10.1186/s13054-019-2588-1

Similar Items